Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sickle cell biotech GBT banks $120M in an above-range IPO
Sickle cell biotech GBT banks $120M in an above-range IPO
Sickle cell biotech GBT banks $120M in an above-range IPO
Submitted by
admin
on August 13, 2015 - 9:48am
Source:
Fierce Biotech
News Tags:
sickle cell disease
IPOs
Global Blood Therapeutics
Headline:
Sickle cell biotech GBT banks $120M in an above-range IPO
Do Not Allow Advertisers to Use My Personal information
